Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation clinical trials

Explore recruiting non small cell lung cancer stages i b ii and selected stages iii a and iii b with oncogenic egfr mutation clinical trials.

Also recruiting in Europe

Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Preoperative amivantamab or amivantamab and carboplatin/pemetrexed treatment in patients with resectable non-small-cell lung cancer harboring oncogenic EGFR mutations (NEOpredict-EGFR)

Germany, Belgium, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation trials by city

Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Toronto Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Vancouver Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Montreal Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Calgary Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Edmonton Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Ottawa Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Winnipeg Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Quebec City Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Hamilton Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Kitchener Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in London Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Halifax Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in New York Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Los Angeles Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Chicago Non Small Cell Lung Cancer Stages I B Ii And Selected Stages Iii A And Iii B With Oncogenic Egfr Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease